Women who consume four or more alcoholic drinks during a single occasion at least once a month face increased odds of developing advanced liver fibrosis.
This new research, published in Alcohol: Clinical & Experimental Research, highlights a critical sex-specific risk threshold for liver damage related to binge drinking patterns.
The findings suggest that the frequency of episodic heavy drinking may be a more potent predictor of liver scarring in women than in men. While previous clinical understanding focused heavily on cumulative daily alcohol intake, this study identifies specific monthly binge-drinking frequencies that correlate with severe Steatotic Liver Disease (SLD) outcomes.
- Binge drinking is a distinct risk factor: For women, consuming 4+ drinks in one sitting once a month or more is linked to advanced liver scarring.
- Sex-specific vulnerability: Men’s liver risk appears more closely tied to total daily alcohol volume, whereas women show a stronger independent link to binge frequency.
- Fibrosis is a critical marker: Advanced fibrosis is a key predictor of mortality and the progression of liver-related diseases.
Advanced liver fibrosis represents the scarring of hepatic tissue, a progressive condition where healthy liver cells are replaced by fibrous connective tissue. This process often follows Steatotic Liver Disease (SLD), a broad category of conditions formerly known as fatty liver disease. SLD encompasses various phenotypes driven by either metabolic dysfunction or alcohol consumption, or a combination of both, often referred to as MetALD.
The study utilized data from the National Health Nutrition Examination Survey (NHANES), analyzing 43,447 nationally representative adult participants over a two-decade period ending in 2020.
A central finding of the research is that the impact of binge drinking is not uniform across genders. The investigators defined binge drinking as 4 or more drinks per occasion for women and 5 or more for men. The data indicated that the odds of advanced fibrosis increased alongside the reported frequency of these episodes.
When researchers controlled for average daily alcohol consumption, the link between binge drinking and advanced fibrosis remained significant for women but did not seem linked in men. This implies that for men, cumulative alcohol exposure is more relevant than binge drinking specifically. For women, however, the pattern of consumption—specifically the frequency of heavy episodic bouts—exerts an independent influence on liver health.
| Participant Group | Binge Drinking Definition | Primary Risk Driver |
|---|---|---|
| Women | 4+ drinks per occasion | Binge frequency (independent of daily volume) |
| Men | 5+ drinks per occasion | Cumulative daily alcohol exposure |
These results have implications for clinical practice. Because the study identifies that more than monthly binge drinking in women presents similar odds of advanced fibrosis as the level of alcohol use implicated in metabolic dysfunction and alcohol-associated liver disease (MetALD), the researchers recommend including binge-drinking history in clinical evaluation.
This study suggests that a “one-size-fits-all” approach to alcohol history may overlook specific vulnerabilities in women. Incorporating detailed binge-drinking frequency into clinical evaluations could allow for earlier intervention.
It is important to note that the study methodology prevented conclusions about causation.
The research, conducted by investigators analyzing the NHANES cohort, shows that alcohol-related liver disease requires sex-specific approaches.
- Dunn, W., et al. (2026). Sex‐Specific Risk Thresholds of Binge‐Drinking Frequency for Advanced Fibrosis in MetALD and ALD: Analysis of the NHANES Cohort. Alcohol: Clinical & Experimental Research.
